Evaluation
Advanced Testing & Review
Members undergo next-generation diagnostic testing that traditional plans do not cover. Phase One begins with a full-spectrum blood biomarker panel, Continuous Glucose Monitoring (CGM), and a comprehensive genetic test. Results are reviewed by clinical specialists who identify pre-symptomatic disease markers before they ever become symptomatic.
- Full-Spectrum Blood Biomarker Panel
- Continuous Glucose Monitoring (CGM)
- Comprehensive Genetic Testing
- Clinical Specialist Review of Results